Business Context and Reporting Period
This Form 8-K is a current report filed by Sonus Pharmaceuticals, Inc. (not Achieve Life Sciences, Inc., as indicated in the metadata) on July 18, 2008, covering events occurring on July 16, 2008. The registrant is a Delaware corporation headquartered in Bothell, Washington.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on a regulatory listing event rather than financial performance data.
Material Changes
The primary material event reported is the resolution of a listing status issue. On July 16, 2008, the NASDAQ Listing Qualifications Panel determined to grant the Company's request to continue the listing of its securities on The NASDAQ Global Market.
Guidance, Outlook, and Risks
The filing contains no management guidance, financial outlook, or discussion of specific risks or contingencies beyond the context of the listing determination. The Company issued a press release on July 17, 2008, to announce the NASDAQ Panel's decision.
Investor Verification Checklist
- Verify the correct registrant name is Sonus Pharmaceuticals, Inc., not Achieve Life Sciences, Inc.
- Confirm the continued listing status on The NASDAQ Global Market following the July 16, 2008 determination.
- Review the attached press release (Exhibit 99.1) for any additional context regarding the listing request.